Search

One size does not fit all when it comes to treating renal cell carcinoma.

… Tuesday, January 15, 2019 Summary Scientists at Memorial Sloan Kettering have identified factors in a tumor’s environment that predict how well it will respond to certain cancer therapies. If cancer is like a weed that sprouts from a seed, then the tumor microenvironment is like the soil that nurtures

Cancer screenings are essential. MSK’s Physician-In-Chief and Chief Medical Officer, Lisa DeAngelis, MD, shared why cancer care screenings are critical during an interview with PBS Metrofocus.

… Friday, August 14, 2020 It’s time to go back. Cancer care is essential care and screenings and treatments can’t wait. That was the message that MSK’s Physician-In-Chief and Chief Medical Officer, Lisa DeAngelis, MD, shared during a recent interview with  PBS Metrofocus .  When COVD-19 first hit the tri-state

The newest edition of the thyroid cancer staging system has increased the age at diagnosis as a prognostic factor by a decade.

… Friday, March 1, 2019 The newest edition of the thyroid cancer staging system has increased the age at diagnosis as a prognostic factor by a decade. To understand the impact of this, and other recent changes, we staged patients using our extensive, prospectively collected database at Memorial Sloan Kettering

MSK investigators find that the presence of certain gene mutations in patients’ blood may mean they are more likely to get a secondary leukemia.

… Thursday, August 10, 2017 Summary MSK investigators have found that the presence of certain gene mutations in patients’ blood may mean they are more likely to get a secondary leukemia. The discovery may lead to new methods for determining who is at greatest risk. One of the most devastating things that

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Thursday, May 7, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Tsvi Gal Is Named MSK’s Head of Infrastructure Tsvi Gal Tsvi Gal Tsvi Gal has been appointed Head of Infrastructure of MSK. Mr. Gal assumed his role on April 28. Mr. Gal will lead the hospital

Men with advanced prostate cancer treated with radical prostatectomy and adjuvant radiotherapy have a lower risk of cancer-specific death and improved overall survival compared to men treated with radiotherapy plus androgen deprivation therapy.

… Thursday, November 8, 2018 Men with advanced prostate cancer treated with radical prostatectomy and adjuvant radiotherapy have a lower risk of cancer-specific death and improved overall survival compared to men treated with radiotherapy plus androgen deprivation therapy, according to our recent observational

The Fellows of the American Association for Cancer Research (AACR) have elected Charles L. Sawyers, MD, chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK), as their President-Elect for 2020–2021.

… Friday, June 12, 2020 The Fellows of the American Association for Cancer Research (AACR) have elected Charles L. Sawyers, MD , chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK), as their President-Elect for 2020–2021. He will assume the presidency

MSK launched the Kravis Women in Science Endeavor (WiSE) in 2020 to pledge a commitment to support gender equity in science. The winners will be recognized at the annual Kravis WiSE Symposium which is held every year during Women’s History Month.

… Wednesday, March 10, 2021 Ms. Regina Bou Puerto and Mijin Kim, PhD Ms. Regina Bou Puerto and Mijin Kim, PhD Memorial Sloan Kettering Cancer Center (MSK) announced that Sloan Kettering Institute (SKI) researchers Regina Bou Puerto and Mijin Kim, PhD , have been named 2021 Marie-Josée Kravis Women in Science

Memorial Sloan Kettering Cancer Center has recruited Sohrab Shah, PhD, to serve as the inaugural Chief of Computational Oncology within the Department of Epidemiology and Biostatistics. In this role, Dr. Shah will lead the effort to build a research program dedicated to harnessing MSK’s numerous “Big Data” resources to translate biologic knowledge to clinical practice.

… Tuesday, April 17, 2018 Memorial Sloan Kettering Cancer Center (MSK) has recruited Sohrab Shah, PhD , to serve as the inaugural Chief of Computational Oncology within the Department of Epidemiology and Biostatistics . In this role, Dr. Shah will lead the effort to build a research program dedicated to

MSK Kids is leading a major effort to fully deliver on the promise of precision medicine for our youngest patients.

… Thursday, October 3, 2019 Rihanna sitting in a chair outside Rihanna before her first birthday. Photo: Ana Plaza MSK Kids pediatric oncologist Neerav “Neal” Shukla Neerav “Neal” Shukla is Director of the Pediatric Translational Medicine Program. Photo: Karsten Moran MSK Kids Chair Andrew Kung MSK Kids